表紙:感染症診断の世界市場予測(~2028年):技術別(従来型、分子型)、エンドユーザー別(病院・クリニック、診断リファレンスラボ、学術研究機関)、地域別の分析
市場調査レポート
商品コード
1064157

感染症診断の世界市場予測(~2028年):技術別(従来型、分子型)、エンドユーザー別(病院・クリニック、診断リファレンスラボ、学術研究機関)、地域別の分析

Infectious Disease Diagnostics Market Forecasts to 2028 - Global Analysis By Technique (Traditional, Molecular), End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Academic Research Institutes) and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
感染症診断の世界市場予測(~2028年):技術別(従来型、分子型)、エンドユーザー別(病院・クリニック、診断リファレンスラボ、学術研究機関)、地域別の分析
出版日: 2022年08月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染症診断の市場規模は、2021年の281億米ドルから、2028年には520億3,000万米ドルに達し、予測期間中のCAGRで9.2%の成長が予測されています。

感染症の流行は世界中で爆発的に増加しており、診断検査に対する需要は拡大しています。

当レポートでは、世界の感染症診断市場について調査分析し、市場概要、市場動向、製品別、検査タイプ別、疾患タイプ別、技術別、エンドユーザー別、地域別の市場分析や、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の感染症診断市場:製品別

  • イントロダクション
  • 試薬、キット、消耗品
  • 機器、システム
  • ソフトウェア、サービス

第6章 世界の感染症診断市場:検査タイプ別

  • イントロダクション
  • 臨床検査
    • 血液検査
    • 検便
    • 尿検査
    • 脊椎穿刺
    • 咽頭スワブ
  • 画像検査
    • コンピュータ断層撮影(CT)
    • 磁気共鳴画像法(MRI)
    • X線
    • 生検
  • ポイントオブケア(POC)検査

第7章 世界の感染症診断市場:疾患タイプ別

  • イントロダクション
  • 細菌感染症(メチシリン耐性黄色ブドウ球菌(MRSA))
  • ウイルス感染
    • COVID-19
    • ヒト・パピローマウイルス(HPV)
  • C型肝炎
  • B型肝炎
  • 心血管感染症
  • 真菌感染症
  • 院内感染(HAI)
  • 呼吸器感染症
    • 結核
    • 気管支炎
    • インフルエンザ
  • 血液感染症
    • 伝染性単核球症
    • マラリア
    • デング熱
  • 下痢性疾患
    • 腸チフス
    • コレラ
    • 細菌性赤痢
  • 中枢神経系(CNS)感染症
    • 脳膿瘍
    • 髄膜炎
  • 性感染症
    • 梅毒
    • クラミジア・トラコマチス性器感染症、淋病(CT/NG)
    • 後天性免疫不全症候群(AIDS)

第8章 世界の感染症診断市場:技術別

  • イントロダクション
  • 従来型
    • グラム染色による病原体の培養
    • 酵素免疫測定法、凝集法
    • 生化学的特性化
    • 免疫診断学
    • 顕微鏡検査
  • 分子型
    • 臨床微生物学
    • 等温核酸増幅法(INAAT)
    • ポリメラーゼ連鎖反応(PCR)
    • マイクロアレイ
    • ハイブリダイゼーション
    • 次世代シーケンシング(NGS)、デオキシリボ核酸(DNA)シーケンシング

第9章 世界の感染症診断市場:エンドユーザー別

  • イントロダクション
  • 病院・クリニック
  • 診断リファレンスラボ
  • 学術研究機関
  • 在宅医療
  • 診療所
  • 開発業務受託機関
  • 外科センター

第10章 世界の感染症診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第11章 主な発展

  • 契約、提携、協業、合弁事業
  • 買収、合併
  • 新製品の発売
  • 拡張
  • その他の重要戦略

第12章 企業プロファイル

  • Becton, Dickinson and Company(BD)
  • Abbott Diagnostic
  • Beckman Coulter
  • Siemens Healthcare Diagnostics
  • Roche Diagnostic
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Meridian Bioscience
  • Corgenix
  • Trinity Biotech
  • Eiken Chemical
  • J.Mitra
  • Diasorin
  • EMD Millipore
  • QuantuMDx
図表

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Reagents, Kits, and Consumables (2020-2028) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments & Systems (2020-2028) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2020-2028) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2020-2028) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Blood Test (2020-2028) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Stool Test (2020-2028) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Urine Test (2020-2028) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Spinal Tap (2020-2028) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Throat Swabs (2020-2028) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2020-2028) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By Computed tomography (CT) (2020-2028) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2020-2028) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By X-ray (2020-2028) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2020-2028) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Point-of-Care (POC) Testing (2020-2028) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2020-2028) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA)) (2020-2028) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By Viral Infection (2020-2028) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By COVID-19 (2020-2028) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2020-2028) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis C (2020-2028) ($MN)
  • Table 25 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis B (2020-2028) ($MN)
  • Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular Infection (2020-2028) ($MN)
  • Table 27 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infection (2020-2028) ($MN)
  • Table 28 Global Infectious Disease Diagnostics Market Outlook, By Hospital Acquired Infections (HAIs) (2020-2028) ($MN)
  • Table 29 Global Infectious Disease Diagnostics Market Outlook, By Respiratory Infections (2020-2028) ($MN)
  • Table 30 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (2020-2028) ($MN)
  • Table 31 Global Infectious Disease Diagnostics Market Outlook, By Bronchitis (2020-2028) ($MN)
  • Table 32 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2020-2028) ($MN)
  • Table 33 Global Infectious Disease Diagnostics Market Outlook, By Blood Infections (2020-2028) ($MN)
  • Table 34 Global Infectious Disease Diagnostics Market Outlook, By Infectious Mononucleosis (2020-2028) ($MN)
  • Table 35 Global Infectious Disease Diagnostics Market Outlook, By Malaria (2020-2028) ($MN)
  • Table 36 Global Infectious Disease Diagnostics Market Outlook, By Dengue (2020-2028) ($MN)
  • Table 37 Global Infectious Disease Diagnostics Market Outlook, By Diarrheal Disease (2020-2028) ($MN)
  • Table 38 Global Infectious Disease Diagnostics Market Outlook, By Enteric/Typhoid Fever (2020-2028) ($MN)
  • Table 39 Global Infectious Disease Diagnostics Market Outlook, By Cholera (2020-2028) ($MN)
  • Table 40 Global Infectious Disease Diagnostics Market Outlook, By Shigellosis (2020-2028) ($MN)
  • Table 41 Global Infectious Disease Diagnostics Market Outlook, By Central Nervous System (CNS) Infection (2020-2028) ($MN)
  • Table 42 Global Infectious Disease Diagnostics Market Outlook, By Brain Abscess (2020-2028) ($MN)
  • Table 43 Global Infectious Disease Diagnostics Market Outlook, By Meningitis (2020-2028) ($MN)
  • Table 44 Global Infectious Disease Diagnostics Market Outlook, By Sexually Transmitted Diseases (2020-2028) ($MN)
  • Table 45 Global Infectious Disease Diagnostics Market Outlook, By Syphilis (2020-2028) ($MN)
  • Table 46 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2020-2028) ($MN)
  • Table 47 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2020-2028) ($MN)
  • Table 48 Global Infectious Disease Diagnostics Market Outlook, By Technique (2020-2028) ($MN)
  • Table 49 Global Infectious Disease Diagnostics Market Outlook, By Traditional (2020-2028) ($MN)
  • Table 50 Global Infectious Disease Diagnostics Market Outlook, By Gram-stain Pathogen Culturing (2020-2028) ($MN)
  • Table 51 Global Infectious Disease Diagnostics Market Outlook, By Enzyme Immunoassay Agglutination (2020-2028) ($MN)
  • Table 52 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2020-2028) ($MN)
  • Table 53 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2020-2028) ($MN)
  • Table 54 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2020-2028) ($MN)
  • Table 55 Global Infectious Disease Diagnostics Market Outlook, By Molecular (2020-2028) ($MN)
  • Table 56 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2020-2028) ($MN)
  • Table 57 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Test (INAAT) (2020-2028) ($MN)
  • Table 58 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2020-2028) ($MN)
  • Table 59 Global Infectious Disease Diagnostics Market Outlook, By Microarrays (2020-2028) ($MN)
  • Table 60 Global Infectious Disease Diagnostics Market Outlook, By Hybridization (2020-2028) ($MN)
  • Table 61 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing (2020-2028) ($MN)
  • Table 62 Global Infectious Disease Diagnostics Market Outlook, By End User (2020-2028) ($MN)
  • Table 63 Global Infectious Disease Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
  • Table 64 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Reference Laboratories (2020-2028) ($MN)
  • Table 65 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2020-2028) ($MN)
  • Table 66 Global Infectious Disease Diagnostics Market Outlook, By Home Healthcare (2020-2028) ($MN)
  • Table 67 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2020-2028) ($MN)
  • Table 68 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2020-2028) ($MN)
  • Table 69 Global Infectious Disease Diagnostics Market Outlook, By Surgical Centers (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented i

目次
Product Code: SMRC21791

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $30.69 billion in 2022 and is expected to reach $52.03 billion by 2028 growing at a CAGR of 9.2% during the forecast period. Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests.

In 2020, molecular technologies accounted for approximately 49 percent of the worldwide organ transplant diagnostics market. This was followed by serology which had a 30 percent market share. By 2031, it was forecast that the market share of molecular technologies would increase to just under 54 percent. In 2020, PCR accounted for approximately 42.7 percent of the worldwide molecular diagnostics market, while next-generation sequencing amounted to 10.4 percent of the market. By 2031, PCR was forecast to have a 43.3 percent share of the molecular diagnostics market.

Market Dynamics:

Driver:

Rising prevalence of infectious diseases

The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics. Hence, it is expected to have a positive impact on this market.

Restraint:

Inadequate reimbursement

Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Opportunity:

Opportunities from developing economies

Developing economies such as India and South Korea are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.

Threat:

Poor distribution channel

Diagnostic kits are expensive and manufacturers still have poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

COVID-19 Impact

Diagnostics for SARS-CoV-2 screening are being developed continuously to cater to the needs of markets with unique regulatory constraints. For example, in November 2021, Detect, a health technology firm, launched a new PCR-quality at-home COVID-19 quick molecular test to address testing needs at home, school, and work, in the United States. Likewise, CoviSwift, by Mylab Discovery Solutions, a point-of-care (POC) RT-PCR testing solution that may be utilized in small labs, in-hospital labs, airports, and communities, was approved and launched in February 2022. Similarly, Abbott introduced the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, in March 2020, and BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes in March 2020.

The reagents, kits, and consumables segment is expected to be the largest during the forecast period

The reagents, kits, and consumables segment is expected to be the largest during the forecast period owing to the factors such as increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. Further, the outbreak of coronavirus (COVID-19) disease is further expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various kits and assays for early disease detection.

The traditional segment is expected to have the highest CAGR during the forecast period

The dominance of traditional segment is mainly attributed to factors such as the increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.

Region with largest share:

North America is projected to hold the largest market share owing to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments. Other factors contributing to the market growth are the increasing prevalence of infectious diseases and high expenditure on healthcare, and an increase in awareness among the population regarding the availability of treatment devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Key players in the market

Some of the key players profiled in the Infectious Disease Diagnostics Market include Becton, Dickinson and Company (BD), Abbott Diagnostic, Beckman Coulter, Siemens Healthcare Diagnostics, Roche Diagnostic, Thermo Fisher Scientific, Bio-Rad Laboratories, Meridian Bioscience, Corgenix, Trinity Biotech, Eiken Chemical, J.Mitra, Diasorin, EMD Millipore, and QuantuMDx.

Key developments:

In July 2021: QuantuMDx launched the rapid polymerase chain reaction point-of-care diagnostic system called Q-POC for COVID-19.

In March 2021: Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

In February 2021: Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Products Covered:

  • Reagents, Kits, and Consumables
  • Instruments & Systems
  • Software & Services

Test Types Covered:

  • Laboratory Tests
  • Imaging Test
  • Point-of-Care (POC) Testing

Disease Types Covered:

  • Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
  • Viral Infection
  • Hepatitis C
  • Hepatitis B
  • Cardiovascular Infection
  • Fungal Infection
  • Hospital Acquired Infections (HAIs)
  • Respiratory Infections
  • Blood Infections
  • Diarrheal Disease
  • Central Nervous System (CNS) Infection
  • Sexually Transmitted Diseases

Techniques Covered:

  • Traditional
  • Molecular

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Reference Laboratories
  • Academic Research Institutes
  • Home Healthcare
  • Physician Offices
  • Contract Research Organization
  • Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents, Kits, and Consumables
  • 5.3 Instruments & Systems
  • 5.4 Software & Services

6 Global Infectious Disease Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Laboratory Tests
    • 6.2.1 Blood Test
    • 6.2.2 Stool Test
    • 6.2.3 Urine Test
    • 6.2.4 Spinal Tap
    • 6.2.5 Throat Swabs
  • 6.3 Imaging Test
    • 6.3.1 Computed tomography (CT)
    • 6.3.2 Magnetic Resonance Imaging (MRI)
    • 6.3.3 X-ray
    • 6.3.4 Biopsies
  • 6.4 Point-of-Care (POC) Testing

7 Global Infectious Disease Diagnostics Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
  • 7.3 Viral Infection
    • 7.3.1 COVID-19
    • 7.3.2 Human Papillomavirus (HPV)
  • 7.4 Hepatitis C
  • 7.5 Hepatitis B
  • 7.6 Cardiovascular Infection
  • 7.7 Fungal Infection
  • 7.8 Hospital Acquired Infections (HAIs)
  • 7.9 Respiratory Infections
    • 7.9.1 Tuberculosis
    • 7.9.2 Bronchitis
    • 7.9.3 Influenza
  • 7.10 Blood Infections
    • 7.10.1 Infectious Mononucleosis
    • 7.10.2 Malaria
    • 7.10.3 Dengue
  • 7.11 Diarrheal Disease
    • 7.11.1 Enteric/Typhoid Fever
    • 7.11.2 Cholera
    • 7.11.3 Shigellosis
  • 7.12 Central Nervous System (CNS) Infection
    • 7.12.1 Brain Abscess
    • 7.12.2 Meningitis
  • 7.13 Sexually Transmitted Diseases
    • 7.13.1 Syphilis
    • 7.13.2 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
    • 7.13.3 Acquired Immunodeficiency Syndrome (AIDS)

8 Global Infectious Disease Diagnostics Market, By Technique

  • 8.1 Introduction
  • 8.2 Traditional
    • 8.2.1 Gram-stain Pathogen Culturing
    • 8.2.2 Enzyme Immunoassay Agglutination
    • 8.2.3 Biochemical Characterization
    • 8.2.4 Immunodiagnostics
    • 8.2.5 Microscopy
  • 8.3 Molecular
    • 8.3.1 Clinical Microbiology
    • 8.3.2 Isothermal Nucleic Acid Amplification Test (INAAT)
    • 8.3.3 Polymerase Chain Reaction (PCR)
    • 8.3.4 Microarrays
    • 8.3.5 Hybridization
    • 8.3.6 Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing

9 Global Infectious Disease Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Diagnostic Reference Laboratories
  • 9.4 Academic Research Institutes
  • 9.5 Home Healthcare
  • 9.6 Physician Offices
  • 9.7 Contract Research Organization
  • 9.8 Surgical Centers

10 Global Infectious Disease Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Becton, Dickinson and Company (BD)
  • 12.2 Abbott Diagnostic
  • 12.3 Beckman Coulter
  • 12.4 Siemens Healthcare Diagnostics
  • 12.5 Roche Diagnostic
  • 12.6 Thermo Fisher Scientific
  • 12.7 Bio-Rad Laboratories
  • 12.8 Meridian Bioscience
  • 12.9 Corgenix
  • 12.10 Trinity Biotech
  • 12.11 Eiken Chemical
  • 12.12 J.Mitra
  • 12.13 Diasorin
  • 12.14 EMD Millipore
  • 12.15 QuantuMDx